Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Qin, Ying ^a   Tian, Ya Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PARVOVIRUS VECTOR; PLASMID DNA; RESISTIN; SOMATOMEDIN C; STAT3 PROTEIN; STAT5 PROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 2, RAT; HUMAN GROWTH HORMONE; RETN PROTEIN, RAT;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER HISTOLOGY; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WESTERN BLOTTING; ANIMAL; BLOOD; ENZYMOLOGY; FATTY LIVER; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; LIPID PEROXIDATION; LIVER; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RANDOMIZATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; FATTY LIVER; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN GROWTH HORMONE; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; RESISTIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954881744     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-78     Document Type: Article

References (57)

1. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. IR Willner B Waters SR Patil A Reuben J Morelli CA Riely, Am J Gastroenterol 2001 96 2957 2961 10.1111/j.1572-0241.2001.04667.x 11693332
2. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. E Bugianesi N Leone E Vanni G Marchesini F Brunello P Carucci A Musso P De Paolis L Capussotti M Salizzoni M Rizzetto, Gastroenterology 2002 123 134 140 10.1053/gast.2002.34168 12105842
3. Nonalcoholic fatty liver disease. P Angulo, N Engl J Med 2002 346 1221 1231 10.1056/NEJMra011775 11961152
4. Nonalcoholic steatohepatitis and the metabolic syndrome. J Jiang N Torok, Metab Syndr Relat Disord 2008 6 1 7 10.1089/met.2007.0026 18370830
5. Fatty infiltration of liver in hyperlipidemic patients. N Assy K Kaita D Mymin C Levy B Rosser G Minuk, Dig Dis Sci 2000 45 1929 1934 10.1023/A:1005661516165 11117562
6. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. XZ Hong LD Li LM Wu, Clin Exp Pharmacol Physiol 2007 34 27 35 10.1111/j.1440-1681.2007.04547.x 17201732
7. Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. CH Gravholt O Schmitz L Simonsen J Bülow JS Christiansen N Møller, Am J Physiol Endocrinol Metab 1999 277 848 E854
8. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. Y Fan RK Menon P Cohen D Hwang T Clemens DJ DiGirolamo JJ Kopchick D Le Roith M Trucco MA Sperling, J Biol Chem 2009 284 19937 19944 10.1074/jbc.M109.014308 19460757
9. Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. T Ichikawa K Nakao K Hamasaki R Furukawa S Tsuruta Y Ueda N Taura H Shibata M Fujimoto K Toriyama K Eguchi, Hepatol Int 2007 1 287 294 10.1007/s12072-007-9007-4 19669352
10. Effect of growth hormone on fatty liver in panhypopituitarism. S Takano S Kanzaki M Sato T Kubo Y Seino, Arch Dis Child 1997 76 537 538 10.1136/adc.76.6.537 9245856
11. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Y Takahashi K Iida K Takahashi S Yoshioka H Fukuoka R Takeno M Imanaka H Nishizawa M Takahashi Y Seo Y Hayashi T Kondo Y Okimura H Kaji R Kitazawa S Kitazawa K Chihara, Gastroenterol 2007 132 938 943 10.1053/j.gastro.2006.12.024 (Pubitemid 46454267)
12. GH treatment in adults with chronic liver disease: A randomized, double-blind, placebo-controlled, cross-over study. DJ Wallace WJ Abbott-johnson DHG Crawford R Barnard JM Potter RC Cuneo, J Clin Endocrinol Metabo 2002 87 2751 2759 10.1210/jc.87.6.2751 (Pubitemid 34657262)
13. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. A Xu Y Wang H Keshaw LY Xu KS Lam GJ Cooper, J Clin Invest 2003 112 91 100 12840063
14. The role of leptin in progression of non-alcoholic fatty liver disease. K Ikejima K Okumura T Lang H Honda W Abe S Yamashina N Enomoto Y Takei N Sato, Hepatol Res 2005 33 151 154 10.1016/j.hepres.2005.09.024 16198623
15. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. K Ikejima Y Takei H Honda M Hirose M Yoshikawa YJ Zhang T Lang T Fukuda S Yamashina T Kitamura N Sato, Gastroenterol 2002 122 1529 1532 10.1053/gast.2002.33369
16. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. C Bertolani P Sancho-Bru P Failli R Bataller S Aleffi R DeFranco B Mazzinghi P Romagnani S Milani P Gines J Colmenero M Parola S Gelmini R Tarquini G Laffi M Pinzani F Marra, Am J Pathol 2006 169 2042 2053 10.2353/ajpath.2006.060081 17148667
17. Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-1 expression. KL Houseknecht CP Portocarrero SJR Lemenager ME Spurlock, J Endocrinol 2000 164 51 57 10.1677/joe.0.1640051 10607937
18. Effects of Growth Hormone (GH) on Ghrelin, Leptin, and Adiponectin in GH-Deficient Patients. B Edén Engström P Burman C Holdstock FA Karlsson, J Clin Endocrinol Metab 2003 88 5193 5198 10.1210/jc.2003-030713 14602749
19. Growth hormone rapidly induces resistin gene expression in white adipose tissue of Spontaneous Dwarf (SDR) rats. PJ Delhanty D Mesotten F McDougall RC Baxter, Endocrinology 2002 143 2445 2448 10.1210/en.143.6.2445 12021211
20. Microarray gene analysis of peripheral whole blood in normal adult male rats after chronic GH gene therapy. Y Qin YP Tian, Cell Mol Biol Lett 2010 15 177 195 10.2478/s11658-010-0001-9 20119855
21. Resveratrol inhibits nonalcoholic fatty liver disease in rats. L Bujanda E Hijona M Larzabal M Beraza P Aldazabal N García-Urkia C Sarasqueta A Cosme B Irastorza A Gonzlez JI Arenas, BMC Gastroenterol 2008 8 40 10.1186/1471-230X-8-40 18782455
22. A novel leptin receptor isoform in rat. MY Wang CB Newgard RH Unger YT Zhou, FEBs lett 1996 392 87 90 10.1016/0014-5793(96)00790-9 8772180
23. Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Y Qin YP Tian, Mol Med Rep 2010 3 525 530 10.3892/mmr-00000292
24. Steatohepatitis: a tale of two "hits"? CP Day OF James, Gastroenterology 1998 114 842 845 10.1016/S0016-5085(98)70599-2 9547102
25. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. N Sabir Y Sermezb S Kazila M Zencirc, Eur J Ultrasound 2001 14 121 128 10.1016/S0929-8266(01)00153-7 11704429
26. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. J Shang LL Chen FX Xiao H Sun HC Ding H Xiao, Acta Pharmacol Sin 2008 29 698 706 10.1111/j.1745-7254.2008.00807.x 18501116
27. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-Infected patients with fat accumulation. JM Schwarz K Mulligan J Lee JC Lo M Wen MA Noor C Grunfeld M Schambelan, J Clin Endocrinol Metab 2002 87 942 945 10.1210/jc.87.2.942 11836345 (Pubitemid 34158275)
28. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. M Ottosson K Vikman-Adolfsson S Enerbäck A Elander P Björntorp S Edén, J Clin Endocrinol Metab 1995 80 936 941 10.1210/jc.80.3.936 7883853
29. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. MA Heffernan AW Thorburn B Fam R Summers B Conway-Campbell MJ Waters FM Ng, J Int J Obes Relat Metab Disord 2001 25 1442 1449 10.1038/sj.ijo.0801740 (Pubitemid 32977859)
30. TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome. S Gwozdziewiczov R Lichnovsk RB Yahia R Chlup J Hebíek, Biomed Papers 2005 149 109 117
31. Gene expression of tumor necrosis factor-a and TNF-receptors, p55 and p75, in non-alcoholic steatohepatitis patients. J Crespo A Cayán P Fernndez-Gil M Hernndez-Guerra M Mayorga A Domínguez-Díez JC Fernndez-Escalante F Pons-Romero, Hepatology 2001 34 1158 1163 10.1053/jhep.2001.29628 11732005
32. Protection from obesity-induced insulin-resistance in mice lacking TNF-alpha function. KT Uysal SM Wiesbrock MW Marino GS Hotamisligil, Nature 1997 389 610 614 10.1038/39335 9335502
33. Cytokines in alcoholic and nonalcoholic steatohepatitis. H Tilg AM Diehl, N Engl J Med 2000 343 1467 75 10.1056/NEJM200011163432007 11078773
34. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. R Polavarapu DR Spitz JE Sim MH Follansbee LW Oberley A Rahemtulla AA Nanji, Hepatology 1998 27 1317 1323 10.1002/hep.510270518 9581686
35. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. T Sariçam B Kircali T Köken, Turk J Gastroenterol 2005 16 65 70 16252194
36. Liver enzyme alteration: A guide for clinicians. EG Giannini R Testa V Savarino, Can Med Assoc J 2005 172 367 379 10.1503/cmaj.1040752 (Pubitemid 40208726)
37. Signaling pathways activated by the growth hormone receptor. J Herrington C Carter-Su, Trends Endocrinol Metab 2001 12 252 257 10.1016/S1043-2760(01) 00423-4 11445442
38. How growth hormone controls growth, obesity and sexual dimorphism. AM Lichanska MJ Waters, Trends Genet 2007 24 41 47 10.1016/j.tig.2007.10.006 18063438
39. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. R Barbuio M Milanski MB Bertolo MJ Saad LA Velloso, J Endocrinol 2007 194 539 550 10.1677/JOE-07-0234 17761893
40. Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. RJ Gum LL Gaede MA Heindel JF Waring JM Trevillyan BA Zinker ME Stark D Wilcox MR Jirousek CM Rondinone RG Ulrich, Mol Endocrinol 2003 17 1131 1143 10.1210/me.2002-0288 12649327
41. Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats. S Aghazadeh R Yazdanparast, Clin Nutr 2010 29 381 385 10.1016/j.clnu.2009.08.014 19748164
42. Glutathione deficiency down-regulates hepatic lipogenesis in rats. C Brandsch T Schmidt D Behn K Weie AS Mueller GI Stangl, Lipids Health Dis 2010 9 50 10.1186/1476-511X-9-50 20482862
43. PPAR-alpha: energy combustion, hypolipidemia, inflammation and cancer. SR Pyper N Viswakarma S Yu JK Reddy, Nucl Recept Signal 2010 8 002 10.1621/nrs.08002 20414453
44. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPAR-alpha and SREBP-1c signaling. XQ Hu YM Wang JF Wang Y Xue ZJ Li K Nagao T Yanagita CH Xue, Lipids Health Dis 2010 9 25 10.1186/1476-511X-9-25 20211032
45. Comparative toxicity and safety profile of fenofibate and other fobric acid derivatives. GF Blane, Am J Med 1987 83 suppl 5B 26 36 10.1016/0002- 9343(87)90868-0 3318450
46. The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients. P Boissonnat P Salen J Guidollet R Ferrera G Dureau J Ninet S Renaud M de Lorgeril, Transplantation 1994 58 245 247 7726891
47. Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. H Yan Y Guo P Zhang L Zu X Dong L Chen J Tian X Fan N Wang X Wu W Gao, Biochem Biophys Res Commun 2005 336 278 287 10.1016/j.bbrc.2005.08.066 (Pubitemid 41253433)
48. Production of recombinant adenoassociated viral vectors. R Snyder X Xiao RJ Samulski, Current Protocols in Human Genetics New York: Wiley, Smith D, 1996 12.1.1 12.2.23
49. Nonalcoholi steatohepatitis: a proposal for grading and staging the histological lesions. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon, Am J Gastroenterol 1999 94 2467 2474 10.1111/j.1572-0241.1999.01377.x 10484010
50. Estimation of HDL-c in the plasma without the use of preparative ultracentrifuge. WT Friedwald RJ Levy DS Fredricken, Clin Chem 1972 18 449 5019119
51. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825
52. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. SM Haffner E Kennedy C Gonzalez MP Stern H Miettinen, Diabetes Care 1996 19 1138 1146 10.2337/diacare.19.10.1138 8886564
53. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. H Ohkawa N Ohishi K Yagi, Anal Biochem 1979 95 351 358 10.1016/0003-2697(79)90738-3 36810
54. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. R Wiest S Das G Cadelina G Garcia-Tsao S Milstien RJ Groszmann, J Clin Invest 1999 104 1223 1233 10.1172/JCI7458 10545521
55. Real-time PCR analysis of leptin and leptin receptor expression in the rat prostate, and effects of leptin on prostatic acid phosphatase release. W Malendowicz M Rucinski AS Belloni A Ziolkowska GG Nussdorfer Z Kwias, Int J Mol Med 2006 18 1097 1100 17089013
56. Leptin and leptin receptors in the prostate and seminal vesicles of the adult rat. W Malendowicz M Rucinski C Macchi R Spinazzi A Ziolkowska GG Nussdorfer Z Kwias, Int J Mol Med 2006 18 615 618 16964413
57. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. R Nogueiras R Gallego O Gualillo JE Caminos T Garcia-Caballero C Dieguez, FEBS Lett 2003 548 21 27 10.1016/S0014-5793(03) 00708-7 12885401